Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human BMI1 Antikörper:
anti-Mouse (Murine) BMI1 Antikörper:
anti-Rat (Rattus) BMI1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal BMI1 Primary Antibody für BI, IHC (f) - ABIN2688857
Dimri, Martinez, Jacobs, Keblusek, Itahana, Van Lohuizen, Campisi, Wazer, Band: The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. in Cancer research 2002
Show all 6 Pubmed References
Human Polyclonal BMI1 Primary Antibody für FACS, IF - ABIN652702
Chagraoui, Niessen, Lessard, Girard, Coulombe, Sauvageau, Meloche, Sauvageau: E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells. in Genes & development 2006
Show all 4 Pubmed References
Human Monoclonal BMI1 Primary Antibody für ICC, FACS - ABIN968985
Edwards, Witherspoon, Wang, Afrasiabi, Pham, Birnbaumer, Lipkin: Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. in Cancer research 2009
Show all 2 Pubmed References
Human Monoclonal BMI1 Primary Antibody für ChIP - ABIN2668619
Lafkas, Rodilla, Huyghe, Mourao, Kiaris, Fre: Notch3 marks clonogenic mammary luminal progenitor cells in vivo. in The Journal of cell biology 2013
Show all 2 Pubmed References
Human Polyclonal BMI1 Primary Antibody für IHC (fro), WB - ABIN2477677
Mandal, Boitano, Maxwell, Lou, Alexander: Ninety-eight penetrating vascular injuries: a review of a two and one-half year experience. in The Journal of trauma 1976
Show all 3 Pubmed References
Human Polyclonal BMI1 Primary Antibody für ICC, IF - ABIN152245
Kang, Qi, Zuo, Wang, Zou, Schwartz, Cheng, Yeh: SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. in Molecular cell 2010
Human Polyclonal BMI1 Primary Antibody für ICC, IF - ABIN257760
Ismail, Andrin, McDonald, Hendzel: BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. in The Journal of cell biology 2010
Human Monoclonal BMI1 Primary Antibody für ChIP, ICC - ABIN4284857
Courel, Friesenhahn, Lees: E2f6 and Bmi1 cooperate in axial skeletal development. in Developmental dynamics : an official publication of the American Association of Anatomists 2008
Human Monoclonal BMI1 Primary Antibody für ICC, IF - ABIN2668620
Bracken, Kleine-Kohlbrecher, Dietrich, Pasini, Gargiulo, Beekman, Theilgaard-Mönch, Minucci, Porse, Marine, Hansen, Helin: The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. in Genes & development 2007
Human Monoclonal BMI1 Primary Antibody für CyTOF, FACS - ABIN4900505
Shen, Chen, Ding, Qi, Cen, Wang, Yao, Chen: BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression. in Journal of cellular and molecular medicine 2014
Upregulation of BMI1 correlates with advanced stages of breast neoplasm, poor prognosis and resistance to radiation and chemotherapy. BMI1 seems to be a key player in EMT (zeige ITK Antikörper), chemo-resistance and cancer stemness. Studies showed that reduction of BMI protein level in tumor cells results in inhibition of cell proliferation, induction of apoptosis, and increases susceptibility to cytotoxic agents and radiation therapy. [review]
Down-regulating Bmi-1 may inhibit the biological properties of CD133+ LCSC by blocking NF-kappaB (zeige NFKB1 Antikörper) signaling pathway, which lays a scientific foundation for the clinical treatment of liver cancer.
BMI1 expression is not associated with Colorectal Cancer.
these findings provide further evidence on the tumor-suppression function of miR (zeige MLXIP Antikörper)-630 in breast cancer, and clarify BMI1 as a novel functional target gene of miR (zeige MLXIP Antikörper)-630.
BMI1 is a potential biomarker in epithelial ovarian cancermanagement, especially for tumor progression and chemo-resistance. Molecular traits, including BMI1 and core genes in Focal adhesion and PI3K (zeige PIK3CA Antikörper)/AKT (zeige AKT1 Antikörper) pathways, might be alternatives as therapeutic targets for EOC.
Through radiotherapy and chemotherapy assays, the function of miR (zeige MLXIP Antikörper)-128a on chemoradiotherapy was evaluated. The correlation of miR (zeige MLXIP Antikörper)-128a with BMI1 was identified by performing real-time PCR.
Study demonstrated that BMI-1 was overexpressed in oesophageal squamous cell cancer (ESCC) cells and was related to poor prognosis in ESCC patients. Its knockdown induces radiosensitivity in ESCC and significantly inhibits cell viability, which may contribute to an increased proportion of cells in the G0/G1 phase and cell apoptosis via suppression of the PI3K (zeige PIK3CA Antikörper)/Akt (zeige AKT1 Antikörper) signaling pathway.
Interaction of BMI1 with polyhomeotic protein PHC2 (zeige PhC2 Antikörper) and homo-oligomerization via ubiquitin-like domain are necessary for H2A ubiquitination activity of PRC1 (zeige PRC1 Antikörper) and for clonogenic potential of U2OS cells.
ur results reveal that miR (zeige MLXIP Antikörper)-203a may regulate cholesteatoma growth and proliferation by targeting Bmi1. These findings provide insight for the development of novel nonsurgical options for cholesteatoma.
that the down-regulated Bmi-1 might inhibit the proliferation, invasion, and migration of gastrointestinal stromal tumor cells
Bmi1 is a marker for a distinct population of castration-resistant luminal epithelial cells enriched in the proximal prostate that can serve as a cell of origin for prostate cancer
Findings extend current knowledge of the role of BMI1 and CHD7 (zeige CHD3 Antikörper) in medulloblastoma pathogenesis, and they raise the possibility that pharmacological targeting of BMI1 or ERK (zeige EPHB2 Antikörper) may be particularly indicated in a subgroup of MB with low expression levels of CHD7 (zeige CHD3 Antikörper)
Many Bmi1-positive cells within the tongue cancer specimens failed to proliferate.
High Expressions of BMI1 is associated with breast cancer.
of Bmi1 in lymphocytes can stimulate osteogenesis in vivo and partially rescue defects in skeletal growth and osteogenesis.
miR (zeige MLXIP Antikörper)-203 is repressed by EZH2 (zeige EZH2 Antikörper) in both embryonic and adult neural stem/progenitor cells (NSPCs). MiR (zeige MLXIP Antikörper)-203 negatively regulates the proliferation of NSPCs. One of PRC1 (zeige PRC1 Antikörper) components, Bmi1, is a downstream target of miR (zeige MLXIP Antikörper)-203 in NSPCs.
Data suggest BMI1 overexpression as a novel mechanism leading to EphA7 (zeige EPHA7 Antikörper) inactivation via H3K27 trimethylation and DNA methylation (zeige HELLS Antikörper) by which BMI-1 controls cell proliferation in the postnatal lateral ventricle wall.
Bmi1 plays an important role in regulating the proliferation of cochlear supporting cells.
Results from this study indicate that estrogen deficiency downregulates BMI-1 and subsequently increases ROS (zeige ROS1 Antikörper), T cell activation, and RANKL (zeige TNFSF11 Antikörper) production in T cells, thus enhancing osteoclastogenesis and accelerating bone loss.
ompounding a previously described Bmi1-transgene and Pten-deficiency prostate cancer mouse model with the Ezh2 (zeige EZH2 Antikörper) transgene did not enhance tumour progression or drive metastasis formation. In conclusion, we here report the generation of a wildtype Ezh2 (zeige EZH2 Antikörper) overexpression mouse model that allows for intravital surveillance of tissues with activated transgene
Bmi1 acts immediately downstream of CCAAT enhancer binding protein-alpha (zeige CEBPA Antikörper) to regulate the survival and self-renewal of hematopoietic stem cells and contribute to the erythropoietic dysplasia.
Pig Bmi1 cDNA is 3,193 bp in length and consists of a 981 bp open reading frame, a 256 bp 5 (zeige HSPD1 Antikörper)' untranslated region (UTR (zeige UTS2R Antikörper)), and a 1,956 bp 3 (zeige BST1 Antikörper)' UTR (zeige UTS2R Antikörper). The transcript contains no signal peptides and there are no transmembrane regions in the pig Bmi1 coded protein.
Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones\; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. In the PRC1 complex, it is required to stimulate the E3 ubiquitin-protein ligase activity of RNF2/RING2 (By similarity).
B lymphoma Mo-MLV insertion region 1 homolog
, murine leukemia viral (bmi-1) oncogene homolog
, polycomb complex protein BMI-1
, polycomb group RING finger protein 4
, polycomb group protein Bmi1
, ring finger protein 51
, BMI1 polycomb ring finger oncogene
, B lymphoma Mo-MLV insertion region 1
, polycomb group ring finger 4
, polycomb complex protein BMI-1-A
, polycomb group RING finger protein 4-A
, B lymphoma Mo-MLV insertion region
, Polycomb group RING finger protein 4-B
, polycomb complex protein BMI-1-B
, polycomb group RING finger protein 4-B
, oncoprotein BMI-1